Lilja Jansson

5.9k total citations
16 papers, 383 citations indexed

About

Lilja Jansson is a scholar working on Genetics, Neurology and Physiology. According to data from OpenAlex, Lilja Jansson has authored 16 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 8 papers in Neurology and 4 papers in Physiology. Recurrent topics in Lilja Jansson's work include Amyotrophic Lateral Sclerosis Research (8 papers), Neurogenetic and Muscular Disorders Research (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Lilja Jansson is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (8 papers), Neurogenetic and Muscular Disorders Research (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Lilja Jansson collaborates with scholars based in Finland, United Kingdom and United States. Lilja Jansson's co-authors include Pentti J. Tienari, Liisa Myllykangas, Raimo Sulkava, Hannu Laaksovirta, Bryan J. Traynor, David Heckerman, Dena Hernández, Jennifer C. Schymick, J. Raphael Gibbs and Michael A. Nalls and has published in prestigious journals such as PLoS ONE, The Lancet Neurology and Neurobiology of Aging.

In The Last Decade

Lilja Jansson

16 papers receiving 378 citations

Peers

Lilja Jansson

NEURO

GENET

PHYSI

NEURO

Anne de Septenville France

NiCole A. Finch United States

Mathieu Gravel Canada

Mark Shabsovich United States

Sofía Ibarburu Uruguay

Lindsey D. Goodman United States

Rohini Raman United Kingdom

Qinming Zhou China

Laura Cervera‐Carles Spain

Kevin McAvoy United States

Anne de Septenville France

Lilja Jansson

247 ×1.1

NEURO

93 ×0.6

GENET

121 ×1.1

PHYSI

120 ×1.1

208 ×2.1

NEURO

Citations per year, relative to Lilja Jansson Lilja Jansson (= 1×) peers Anne de Septenville

Countries citing papers authored by Lilja Jansson

Since Specialization

Citations

This map shows the geographic impact of Lilja Jansson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lilja Jansson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lilja Jansson more than expected).

Fields of papers citing papers by Lilja Jansson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lilja Jansson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lilja Jansson. The network helps show where Lilja Jansson may publish in the future.

Co-authorship network of co-authors of Lilja Jansson

This figure shows the co-authorship network connecting the top 25 collaborators of Lilja Jansson. A scholar is included among the top collaborators of Lilja Jansson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lilja Jansson. Lilja Jansson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Nurmi, Katariina, Mari Ainola, Janne Nieminen, et al.. (2024). Epstein-Barr Virus in the Cerebrospinal Fluid and Blood Compartments of Patients With Multiple Sclerosis and Controls. Neurology Neuroimmunology & Neuroinflammation. 11(3). e200226–e200226. 3 indexed citations

Kaivola, Karri, Matti Pirinen, Hannu Laaksovirta, et al.. (2023). C9orf72 hexanucleotide repeat allele tagging SNPs: Associations with ALS risk and longevity. Frontiers in Genetics. 14. 1087098–1087098. 2 indexed citations

Järvinen, Elina, Fumi Suomi, James B. Stewart, et al.. (2023). Cultured lymphocytes’ mitochondrial genome integrity is not altered by cladribine. Clinical & Experimental Immunology. 214(3). 304–313. 1 indexed citations

Laaksovirta, Hannu, Jyrki Launes, Lilja Jansson, et al.. (2022). ALS in Finland. Neurology Genetics. 8(2). e665–e665. 9 indexed citations

Valori, Miko, et al.. (2022). High prevalence of low-allele-fraction somatic mutations in STAT3 in peripheral blood CD8+ cells in multiple sclerosis patients and controls. PLoS ONE. 17(11). e0278245–e0278245. 5 indexed citations

Valori, Miko, Lilja Jansson, & Pentti J. Tienari. (2021). CD8+ cell somatic mutations in multiple sclerosis patients and controls—Enrichment of mutations in STAT3 and other genes implicated in hematological malignancies. PLoS ONE. 16(12). e0261002–e0261002. 16 indexed citations

Kaivola, Karri, Lilja Jansson, Jyrki Launes, et al.. (2020). Carriership of two copies of C9orf72 hexanucleotide repeat intermediate-length alleles is a risk factor for ALS in the Finnish population. Acta Neuropathologica Communications. 8(1). 187–187. 13 indexed citations

Kaivola, Karri, Lilja Jansson, Johan G. Eriksson, et al.. (2019). C9orf72 hexanucleotide repeat length in older population: normal variation and effects on cognition. Neurobiology of Aging. 84. 242.e7–242.e12. 11 indexed citations

Kaivola, Karri, Lilja Jansson, Elmo Saarentaus, et al.. (2017). Heterozygous TYROBP deletion (PLOSLFIN) is not a strong risk factor for cognitive impairment. Neurobiology of Aging. 64. 159.e1–159.e4. 3 indexed citations

10.

Valori, Miko, Lilja Jansson, Kimmo Porkka, et al.. (2016). Lymphoid somatic mutations in multiple sclerosis. Multiple Sclerosis Journal. 22. 170–171. 2 indexed citations

11.

Valori, Miko, Lilja Jansson, Pekka Ellonen, et al.. (2016). A novel class of somatic mutations in blood detected preferentially in CD8 + cells. Clinical Immunology. 175. 75–81. 31 indexed citations

12.

Hartikainen, Päivi, Maritta Siloaho, Seppo Helisalmi, et al.. (2016). Cerebrospinal Fluid TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis Patients with and without the C9ORF72 Hexanucleotide Expansion. Dementia and Geriatric Cognitive Disorders Extra. 6(1). 142–149. 42 indexed citations

13.

Herukka, Sanna‐Kaisa, Päivi Hartikainen, Seppo Helisalmi, et al.. (2015). Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Patients with Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis with the <b><i>C9ORF72 </i></b>Repeat Expansion. Dementia and Geriatric Cognitive Disorders. 39(5-6). 287–293. 16 indexed citations

14.

Kero, Mia, Anders Paetau, Tuomo Polvikoski, et al.. (2012). Amyloid precursor protein (APP) A673T mutation in the elderly Finnish population. Neurobiology of Aging. 34(5). 1518.e1–1518.e3. 54 indexed citations

15.

Martikainen, Mika H., Maria Gardberg, Lilja Jansson, et al.. (2012). Brain¹⁸F-FDG and¹¹C-PiB PET findings in two siblings with FTD/ALS associated with theC9ORF72repeat expansion. Neurocase. 20(2). 150–157. 11 indexed citations

16.

Laaksovirta, Hannu, Terhi Peuralinna, Jennifer C. Schymick, et al.. (2010). Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study. The Lancet Neurology. 9(10). 978–985. 164 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact